28 May 2020

URV Activ@ - Diari digital de la Universitat Rovira i Virgili ·

Advanced search

Martí i Franquès COFUND fellowship programme

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”

Researchers from the NFOC-Salut group at the URV have analysed the results of the latest studies carried out in the frame of the AppleCOR project, which examines the effect of consuming anthocyanin-rich apple flesh on reducing cholesterol